Table 2.
Roles of MMP-7 in kidney diseases.
| Disease | Role of MMP-7 | Ref. |
|---|---|---|
| AKI 1 | Protecting against AKI by priming tubular cells for proliferation and survival | [11] |
| UUO 2 | Promoting renal fibrosis by activating partial EMT and β-catenin | [12] |
| Proteinuric CKD 3 |
Increasing urinary albumin excretion by impairing the glomerular filtration barrier | [7] |
| Diabetic nephropathy | Initiating diabetic nephropathy by expanding glomerular mesangium and thickening glomerular basement membrane | [79] |
| Chronic allograft nephropathy | MMPs, including MMP-7, contribute to the deregulation of extracellular matrix remodeling and possibly EMT. | [29] |
| Light chain deposition disease | The decrease of MMPs, including MMP-7, leads to the accumulation of tenascin and extracellular matrix | [30] |
| Amyloid light- chain amyloidosis |
The increase of MMPs, including MMP-7, leads to the reduction of extracellular matrix | [30] |
| Renal cell carcinoma | Affecting tumor progression by regulating invasion and angiogenesis | [22] |
1 Acute kidney injury. 2 Unilateral ureteral obstruction. 3 Chronic kidney disease.